Archive · 2 Jul 2025
Torrent Pharma to Acquire JB Chemicals in Major Deal
Torrent Pharma, a big medicine company, is buying a large part of JB Chemicals, another medicine company.
This is a very expensive deal, the biggest one Torrent has ever made!
Torrent will take over JB Chemicals step by step.
After the deal, Torrent will become even bigger and stronger in the medicine market.
Experts think this is a good move, although it may take a few years to really see the benefits.
Torrent Pharma is acquiring a controlling stake in JB Chemicals & Pharmaceuticals.
The deal is valued at ₹25,689 crore, making it Torrent's largest acquisition.
Torrent will initially acquire a 46.4% stake, followed by an open offer.
The merger is expected to increase Torrent's market share and strengthen its position.
The acquisition is expected to be earnings accretive from FY28.
- Who
- Torrent Pharma and JB Chemicals & Pharmaceuticals
- What
- Torrent Pharma is acquiring a controlling stake in JB Chemicals & Pharmaceuticals.
- When
- Torrent is expected to gain operational control by Q4FY26.
- Where
- India
- Why
- To strengthen Torrent Pharma's position in the Indian pharmaceutical market and expand its presence in chronic therapies.
Financial Concerns
Strategic Benefits
Debt Levels
Financial Concerns
Increased leverage in the short term.
Strategic Benefits
Improved cash flow and debt reduction anticipated.
- Deal Value
- ₹25,689 crore
- Initial Stake
- 46.4%
- Acquisition Stage
- Multi-phased
- Combined Market Rank
- Fifth (post-merger)
- Expected Earnings Accretion
- FY28
- JB Chemicals Revenue Growth (FY21-FY25)
- Nearly Doubled
